Cytosorbents Corporation 8-K Filing: December 2024 Update
Based on the provided XML section from the financial report, here are the key pieces of information extracted:
- Company Information:
- Name: Cytosorbents Corporation
- CIK (Central Index Key): 0001175151
- SEC File Number: 001-36792
- EIN (Employer Identification Number): 98-0373793
- Address: 305 College Road East, Princeton, NJ 08540
- Contact Number: 732-329-8885
- Stock Information:
- Security: Common Stock
- Par Value: $0.001
- Ticker Symbol: CTSO
- Exchange: NASDAQ
- Filing Details:
- Form Type: 8-K (This form is used to report major events that shareholders should know about)
- Filing Date: December 23, 2024
- Context and Period:
- Context ID: AsOf2024-12-23
- Period Start Date: December 23, 2024
- Period End Date: December 23, 2024
- Currency and Units:
- Currency: USD (United States Dollar)
- Share Unit Measurement: Shares
Insights:
- The report indicates a significant event or update as represented by the 8-K filing, which is typically used for reporting material events. Stakeholders should look for further details in the full 8-K document to understand the context of this filing.
- The company is publicly traded on NASDAQ under the ticker CTSO, which provides liquidity and access to capital markets.
- The filing date and context suggest that this is a recent update, making it relevant for investors and analysts monitoring the company’s performance and news.
This summary encapsulates the critical aspects of the provided financial report section that would be of interest to investors and analysts.